{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:59:57Z","timestamp":1790683197330,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00134-026-08560-w","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:23:08Z","timestamp":1784539388000},"page":"2211-2219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolution of drug-induced acute kidney injury: mechanistic assessment to guide patient care"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7523-4846","authenticated-orcid":false,"given":"Sandra L.","family":"Kane-Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"8560_CR1","doi-asserted-by":"publisher","first-page":"1459170","DOI":"10.3389\/fmed.2024.1459170","volume":"11","author":"G Garcia","year":"2024","unstructured":"Garcia G, Pacchini VR, Zamoner W, Balbi AL, Ponce D (2024) Drug-induced acute kidney injury: a cohort study on incidence, identification of pathophysiological mechanisms, and prognostic factors. Front Med (Lausanne) 11:1459170. https:\/\/doi.org\/10.3389\/fmed.2024.1459170","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"8560_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s13054-023-04720-2","volume":"27","author":"I Karimzadeh","year":"2023","unstructured":"Karimzadeh I, Barreto EF, Kellum JA, Awdishu L, Murray PT, Ostermann M et al (2023) Moving toward a contemporary classification of drug-induced kidney disease. Crit Care 27(1):435. https:\/\/doi.org\/10.1186\/s13054-023-04720-2","journal-title":"Crit Care"},{"issue":"10","key":"8560_CR3","doi-asserted-by":"publisher","first-page":"e2019209","DOI":"10.1001\/jamanetworkopen.2020.19209","volume":"3","author":"M Ostermann","year":"2020","unstructured":"Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R et al (2020) Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open 3(10):e2019209. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19209. (Erratum in: JAMA Netw Open. 2020;3(11):e2029182. 10.1001\/jamanetworkopen.2020.29182)","journal-title":"JAMA Netw Open"},{"issue":"8","key":"8560_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.mayocp.2026.01.031","volume":"51","author":"M Ostermann","year":"2025","unstructured":"Ostermann M, Forni LG, Joannidis M, Kane-Gill SL, Legrand M, Lumlertgul N et al (2025) State of the art: renal recovery after AKI\u2014from basic science to clinical practice. Intensive Care Med 51(8):1490\u20131507. https:\/\/doi.org\/10.1016\/j.mayocp.2026.01.031","journal-title":"Intensive Care Med"},{"issue":"3","key":"8560_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000440867","volume":"131","author":"F Paquette","year":"2015","unstructured":"Paquette F, Bernier-Jean A, Brunette V, Ammann H, Lavergne V, Pichette V et al (2015) Acute kidney injury and renal recovery with the use of aminoglycosides: a large retrospective study. Nephron 131(3):153\u2013160. https:\/\/doi.org\/10.1159\/000440867","journal-title":"Nephron"},{"issue":"1","key":"8560_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/0886022X.2022.2036618","volume":"44","author":"M Tashiro","year":"2022","unstructured":"Tashiro M, Obata Y, Takazono T, Ota Y, Wakamura T, Shiozawa Y et al (2022) Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study. Ren Fail 44(1):282\u2013292","journal-title":"Ren Fail"},{"issue":"4","key":"8560_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.2215\/CJN.06980717","volume":"13","author":"TA Miano","year":"2018","unstructured":"Miano TA, Lautenbach E, Wilson FP, Guo W, Borovskiy Y, Hennessy S (2018) Attributable risk and time course of colistin-associated acute kidney injury. Clin J Am Soc Nephrol 13(4):542\u2013550. https:\/\/doi.org\/10.2215\/CJN.06980717","journal-title":"Clin J Am Soc Nephrol"},{"key":"8560_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/IPRP.S52930","volume":"4","author":"BL McDaniel","year":"2015","unstructured":"McDaniel BL, Bentley ML (2015) The role of medications and their management in acute kidney injury. Integr Pharm Res Pract 4:21\u201329. https:\/\/doi.org\/10.2147\/IPRP.S52930","journal-title":"Integr Pharm Res Pract"},{"issue":"7","key":"8560_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/jcp-2023-209173","volume":"77","author":"S Jin","year":"2024","unstructured":"Jin S, Shen Z, Li J, Liu X, Zhu Q, Li F et al (2024) Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy. J Clin Pathol 77(7):471\u2013477. https:\/\/doi.org\/10.1136\/jcp-2023-209173","journal-title":"J Clin Pathol"},{"issue":"5","key":"8560_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/atm-20-3826","volume":"9","author":"Y Cui","year":"2021","unstructured":"Cui Y, Yang Y, Lei W, Lang X, Chen J (2021) The clinicopathological features of drug-induced acute kidney injury-a single-center retrospective analysis. Ann Transl Med 9(5):400. https:\/\/doi.org\/10.21037\/atm-20-3826","journal-title":"Ann Transl Med"},{"issue":"4","key":"8560_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/cpt.70169","volume":"119","author":"W Alatawi","year":"2026","unstructured":"Alatawi W, Wallace JL, Rungkitwattanakul D, Stottlemyer BA, Tran TL, Reida MM et al (2026) Risk of acute kidney injury associated with nephrotoxic burden in hospitalized patients: a scoping review. Clin Pharmacol Ther 119(4):891\u2013904. https:\/\/doi.org\/10.1002\/cpt.70169","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"8560_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bcp.13449","volume":"84","author":"M Ostermann","year":"2018","unstructured":"Ostermann M, Chawla LS, Forni LG, Kane-Gill SL, Kellum JA, Koyner J et al (2018) Drug management in acute kidney disease\u2014report of the acute disease quality initiative XVI meeting. Br J Clin Pharmacol 84(2):396\u2013403. https:\/\/doi.org\/10.1111\/bcp.13449","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"8560_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.2015.115","volume":"88","author":"RL Mehta","year":"2015","unstructured":"Mehta RL, Awdishu L, Davenport A, Murray PT, Macedo E, Cerda J et al (2015) Phenotype standardization for drug-induced kidney disease. Kidney Int 88(2):226\u2013234. https:\/\/doi.org\/10.1038\/ki.2015.115","journal-title":"Kidney Int"},{"issue":"4","key":"8560_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40264-022-01173-4","volume":"45","author":"MP Gray","year":"2022","unstructured":"Gray MP, Barreto EF, Schreier DJ, Kellum JA, Suh K, Kashani KB et al (2022) Consensus obtained for the nephrotoxic potential of 167 drugs in adult critically ill patients using a modified Delphi method. Drug Saf 45(4):389\u2013398. https:\/\/doi.org\/10.1007\/s40264-022-01173-4","journal-title":"Drug Saf"},{"key":"8560_CR15","doi-asserted-by":"publisher","first-page":"21183","DOI":"10.1038\/s41598-021-00710-y","volume":"11","author":"I Fuentes-Calvo","year":"2021","unstructured":"Fuentes-Calvo I, Cuesta C, Sancho-Mart\u00ednez SM et al (2021) Biomarkers of persistent renal vulnerability after acute kidney injury recovery. Sci Rep 11:21183. https:\/\/doi.org\/10.1038\/s41598-021-00710-y","journal-title":"Sci Rep"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-026-08560-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-026-08560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:22:53Z","timestamp":1790680973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-026-08560-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8560"],"URL":"https:\/\/doi.org\/10.1007\/s00134-026-08560-w","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SKG receives grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases R01 DK121730 and U01DK130010. MO received research funding from Biomerieux and Vantive (paid to institution). JAK discloses consulting fees from AstraZeneca, Baxter, Bayer, bioM\u00e9rieux, Chugai Pharma, Mitsubishi Tenabe, and is a full-time employee of Spectral Medical.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}